Literature DB >> 3983356

Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination.

D N Bateman, P G Blain, K W Woodhouse, M D Rawlins, H Dyson, R Heyworth, L F Prescott, A T Proudfoot.   

Abstract

We report clinical details in 16 cases of quinine poisoning. Plasma quinine concentrations above 15 mg/l were associated with increased risks of permanent visual damage and of cardiac arrhythmias from which one of our patients died. The rate of quinine elimination was not significantly altered by forced acid diuresis in five patients (t 1/2 25.1 +/- SEM 4.6 h) as compared to eight patients treated conservatively (t 1/2 26.5 +/- SEM 5.78 h). Neither urinary pH or flow rate correlated consistently with urinary quinine clearance. In three other patients charcoal column haemoperfusion, haemodialysis and exchange transfusion were performed. These were also ineffective in increasing quinine elimination. It is concluded that techniques advocated to increase quinine elimination are ineffective in the management of quinine poisoning.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3983356

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  19 in total

1.  The management of quinine-induced blindness.

Authors:  U Guly; P Driscoll
Journal:  Arch Emerg Med       Date:  1992-09

2.  Relatively spared central multifocal electroretinogram responses in acute quinine toxicity.

Authors:  Muhammad Usman Saeed; Carmel Noonan; Richard Hagan; Malcolm Brown
Journal:  BMJ Case Rep       Date:  2011-07-07

3.  Role of quinine in life-threatening Babesia divergens infection successfully treated with clindamycin.

Authors:  C Corpelet; P Vacher; F Coudore; H Laurichesse; N Conort; B Souweine
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

4.  Ocular quinine toxicity.

Authors:  C R Canning; S Hague
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

5.  Hypoglycaemia and antimalarial drugs: quinidine and release of insulin.

Authors:  R E Phillips; S Looareesuwan; N J White; P Chanthavanich; J Karbwang; W Supanaranond; R C Turner; D A Warrell
Journal:  Br Med J (Clin Res Ed)       Date:  1986-05-17

6.  Effect of oral activated charcoal on quinine elimination.

Authors:  D Lockey; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

7.  Treatment of quinine overdosage with repeated oral charcoal.

Authors:  L F Prescott; A R Hamilton; R Heyworth
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

8.  Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem.

Authors:  N J Langford; A M Good; W J Laing; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

9.  Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine.

Authors:  Paul Acheampong; Gill Cooper; Behshad Khazaeli; David J Lupton; Sue White; Margaret T May; Simon H L Thomas
Journal:  Br J Clin Pharmacol       Date:  2013-12       Impact factor: 4.335

Review 10.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.